Indian Generic Players Begin Price War Over Generic Empagliflozin Launches

The Launches Follow The Expiry of Boehringer’s Patents For The Blockbuster Drug

 
• By Adam Zamecnik
  
India
Pharma In India Working With Stakeholders To Maintain Supplies • Source: Shutterstock

More from Generics

More from Generics Bulletin